Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Scilex Holding Company ( (SCLX) ) has issued an update.
On April 22, 2025, Scilex Holding Company announced a change in the record date for its previously announced dividend of Series 1 Mandatory Exchangeable Preferred Stock from April 11, 2025, to May 2, 2025. This adjustment allows the Board of Directors to determine the payment date within 60 days following the new record date, with the possibility of further changes. The announcement impacts the company’s operations by potentially altering the timing of dividend payments, which could affect stakeholders’ expectations and financial planning.
More about Scilex Holding Company
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases. The company targets indications with high unmet needs and large market opportunities, offering products such as ZTlido®, ELYXYB®, and Gloperba®, and has several product candidates in development, including SEMDEXA™, SP-103, and SP-104.
YTD Price Performance: -68.50%
Average Trading Volume: 51,144
Technical Sentiment Signal: Buy
Current Market Cap: $32.63M
For a thorough assessment of SCLX stock, go to TipRanks’ Stock Analysis page.